Skip to main content

An update on an incident involving one of our systems

Hide
Quest Diagnostics

Comparison of SARS-CoV-2 RT-PCR Ct Values Across Multiple Assays With Different Targets

Comparison of SARS-CoV-2 RT-PCR Ct Values Across Multiple Assays With Different Targets

Authors: Pratt GW, Rao LV

Citation: J Appl Lab Med. 2023 Aug 23:jfad057. doi: 10.1093/jalm/jfad057. Online ahead of print.

Specialties: Infectious Disease, COVID-19

Related content

Conference Presentation
Correlates of immunity in SARS-CoV-2 post-vaccine infectious in the Prospective Assessment of SARS-CoV-2 Seroconversion (PASS) Study
Publication
Risk of and duration of protection from SARS CoV 2 reinfection assessed with real world data
Publication
SARS-CoV-2 Spike-Protein Targeted Serology Test Results and Their Association With Subsequent COVID-19-Related Outcomes
Rapid and Accurate Identification of SARS-CoV-2 Variants Using Real Time PCR Assays
Publication
Assessing vulnerability to COVID 19 in high risk populations: the role of SARS CoV 2 spike targeted serology

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA-certified laboratories that provide HIPAA-covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA-covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2026 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only. May include AI-generated and/or AI-modified imagery.